University Health Network, Toronto: Hepatitis B trials
The registry lists 10 Hepatitis B studies with University Health Network, Toronto as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 2Phase 4 3No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV DonorsRecruitingNCT07189377Phase 4
- Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]RecruitingNCT06216470Phase 2
- Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:Status unknownNCT04070079Phase 4
- Use of TDF in Patients With Inactive Chronic Hepatitis B InfectionCompletedNCT02600117Phase 3
- Tenofovir to Prevent HBV ReactivationStatus unknownNCT02186574Phase 3
- Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide AnaloguesStatus unknownNCT01911156Phase 4
- Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral TherapyStatus unknownNCT00188240Not applicable
- Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral MedicationStatus unknownNCT00188201
- Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisStatus unknownNCT00160940
- Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg NegativeStatus unknownNCT00152880